Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats

In this study was evaluated the chronic cardiac effects of a formulation developed by including angiotensin(Ang)-(1–7) in hydroxypropyl β-cyclodextrin (HPβCD), in infarcted rats. Myocardial infarction (MI) was induced by left coronary artery occlusion. HPβCD/Ang-(1–7) was administered for 60 days (7...

Full description

Saved in:
Bibliographic Details
Main Authors: Fúlvia D. Marques, Marcos B. Melo, Leandro E. Souza, Maria Claúdia C. Irigoyen, Rúben D. Sinisterra, Frederico B. de Sousa, Sílvia Q. Savergnini, Vinícius B. A. Braga, Anderson J. Ferreira, Robson A. S. Santos
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2012/795452
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563420554067968
author Fúlvia D. Marques
Marcos B. Melo
Leandro E. Souza
Maria Claúdia C. Irigoyen
Rúben D. Sinisterra
Frederico B. de Sousa
Sílvia Q. Savergnini
Vinícius B. A. Braga
Anderson J. Ferreira
Robson A. S. Santos
author_facet Fúlvia D. Marques
Marcos B. Melo
Leandro E. Souza
Maria Claúdia C. Irigoyen
Rúben D. Sinisterra
Frederico B. de Sousa
Sílvia Q. Savergnini
Vinícius B. A. Braga
Anderson J. Ferreira
Robson A. S. Santos
author_sort Fúlvia D. Marques
collection DOAJ
description In this study was evaluated the chronic cardiac effects of a formulation developed by including angiotensin(Ang)-(1–7) in hydroxypropyl β-cyclodextrin (HPβCD), in infarcted rats. Myocardial infarction (MI) was induced by left coronary artery occlusion. HPβCD/Ang-(1–7) was administered for 60 days (76 μg/Kg/once a day/gavage) starting immediately before infarction. Echocardiography was utilized to evaluate usual cardiac parameters, and radial strain method was used to analyze the velocity and displacement of myocardial fibers at initial time and 15, 30, and 50 days after surgery. Real-time PCR was utilized to evaluate the fibrotic signaling involved in the remodeling process. Once-a-day oral HPβCD/Ang-(1–7) administration improved the cardiac function and reduced the deleterious effects induced by MI on TGF-β and collagen type I expression, as well as on the velocity and displacement of myocardial fibers. These findings confirm cardioprotective effects of Ang-(1–7) and indicate HPβCD/Ang-(1–7) as a feasible formulation for long-term oral administration of this heptapeptide.
format Article
id doaj-art-3ccaabce7df040ccbcf7fcb7c6ced107
institution Kabale University
issn 2090-0384
2090-0392
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-3ccaabce7df040ccbcf7fcb7c6ced1072025-02-03T01:20:13ZengWileyInternational Journal of Hypertension2090-03842090-03922012-01-01201210.1155/2012/795452795452Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted RatsFúlvia D. Marques0Marcos B. Melo1Leandro E. Souza2Maria Claúdia C. Irigoyen3Rúben D. Sinisterra4Frederico B. de Sousa5Sílvia Q. Savergnini6Vinícius B. A. Braga7Anderson J. Ferreira8Robson A. S. Santos9National Institute of Science and Technology in Nanobiopharmaceutics, Federal University of Minas Gerais, 31.270-901 Belo Horizonte, MG, BrazilNational Institute of Science and Technology in Nanobiopharmaceutics, Federal University of Minas Gerais, 31.270-901 Belo Horizonte, MG, BrazilNational Institute of Science and Technology in Nanobiopharmaceutics, Federal University of Minas Gerais, 31.270-901 Belo Horizonte, MG, BrazilNational Institute of Science and Technology in Nanobiopharmaceutics, Federal University of Minas Gerais, 31.270-901 Belo Horizonte, MG, BrazilNational Institute of Science and Technology in Nanobiopharmaceutics, Federal University of Minas Gerais, 31.270-901 Belo Horizonte, MG, BrazilNational Institute of Science and Technology in Nanobiopharmaceutics, Federal University of Minas Gerais, 31.270-901 Belo Horizonte, MG, BrazilNational Institute of Science and Technology in Nanobiopharmaceutics, Federal University of Minas Gerais, 31.270-901 Belo Horizonte, MG, BrazilDepartment of Morphology, Federal University of Minas Gerais, 31.270-901 Belo Horizonte, MG, BrazilNational Institute of Science and Technology in Nanobiopharmaceutics, Federal University of Minas Gerais, 31.270-901 Belo Horizonte, MG, BrazilNational Institute of Science and Technology in Nanobiopharmaceutics, Federal University of Minas Gerais, 31.270-901 Belo Horizonte, MG, BrazilIn this study was evaluated the chronic cardiac effects of a formulation developed by including angiotensin(Ang)-(1–7) in hydroxypropyl β-cyclodextrin (HPβCD), in infarcted rats. Myocardial infarction (MI) was induced by left coronary artery occlusion. HPβCD/Ang-(1–7) was administered for 60 days (76 μg/Kg/once a day/gavage) starting immediately before infarction. Echocardiography was utilized to evaluate usual cardiac parameters, and radial strain method was used to analyze the velocity and displacement of myocardial fibers at initial time and 15, 30, and 50 days after surgery. Real-time PCR was utilized to evaluate the fibrotic signaling involved in the remodeling process. Once-a-day oral HPβCD/Ang-(1–7) administration improved the cardiac function and reduced the deleterious effects induced by MI on TGF-β and collagen type I expression, as well as on the velocity and displacement of myocardial fibers. These findings confirm cardioprotective effects of Ang-(1–7) and indicate HPβCD/Ang-(1–7) as a feasible formulation for long-term oral administration of this heptapeptide.http://dx.doi.org/10.1155/2012/795452
spellingShingle Fúlvia D. Marques
Marcos B. Melo
Leandro E. Souza
Maria Claúdia C. Irigoyen
Rúben D. Sinisterra
Frederico B. de Sousa
Sílvia Q. Savergnini
Vinícius B. A. Braga
Anderson J. Ferreira
Robson A. S. Santos
Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats
International Journal of Hypertension
title Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats
title_full Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats
title_fullStr Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats
title_full_unstemmed Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats
title_short Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats
title_sort beneficial effects of long term administration of an oral formulation of angiotensin 1 7 in infarcted rats
url http://dx.doi.org/10.1155/2012/795452
work_keys_str_mv AT fulviadmarques beneficialeffectsoflongtermadministrationofanoralformulationofangiotensin17ininfarctedrats
AT marcosbmelo beneficialeffectsoflongtermadministrationofanoralformulationofangiotensin17ininfarctedrats
AT leandroesouza beneficialeffectsoflongtermadministrationofanoralformulationofangiotensin17ininfarctedrats
AT mariaclaudiacirigoyen beneficialeffectsoflongtermadministrationofanoralformulationofangiotensin17ininfarctedrats
AT rubendsinisterra beneficialeffectsoflongtermadministrationofanoralformulationofangiotensin17ininfarctedrats
AT fredericobdesousa beneficialeffectsoflongtermadministrationofanoralformulationofangiotensin17ininfarctedrats
AT silviaqsavergnini beneficialeffectsoflongtermadministrationofanoralformulationofangiotensin17ininfarctedrats
AT viniciusbabraga beneficialeffectsoflongtermadministrationofanoralformulationofangiotensin17ininfarctedrats
AT andersonjferreira beneficialeffectsoflongtermadministrationofanoralformulationofangiotensin17ininfarctedrats
AT robsonassantos beneficialeffectsoflongtermadministrationofanoralformulationofangiotensin17ininfarctedrats